These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 15277497

  • 1. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H, Robinson MR, Lizak MJ, Tansey G, Lutz RJ, Yuan P, Wang NS, Csaky KG.
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [Abstract] [Full Text] [Related]

  • 2. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging.
    Kim SH, Galbán CJ, Lutz RJ, Dedrick RL, Csaky KG, Lizak MJ, Wang NS, Tansey G, Robinson MR.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):808-14. PubMed ID: 17251481
    [Abstract] [Full Text] [Related]

  • 3. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
    Okabe K, Kimura H, Okabe J, Ogura Y.
    Retina; 2007 Feb; 27(6):770-7. PubMed ID: 17621189
    [Abstract] [Full Text] [Related]

  • 4. GD-DTPA enhanced MRI of ocular transport in a rat model of chronic glaucoma.
    Chan KC, Fu QL, Guo H, So KF, Wu EX.
    Exp Eye Res; 2008 Oct; 87(4):334-41. PubMed ID: 18639546
    [Abstract] [Full Text] [Related]

  • 5. Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging.
    Kim H, Lizak MJ, Tansey G, Csaky KG, Robinson MR, Yuan P, Wang NS, Lutz RJ.
    Ann Biomed Eng; 2005 Feb; 33(2):150-64. PubMed ID: 15771269
    [Abstract] [Full Text] [Related]

  • 6. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR, Baffi J, Yuan P, Sung C, Byrnes G, Cox TA, Csaky KG.
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [Abstract] [Full Text] [Related]

  • 7. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents.
    Kimura J, Ishiguchi T, Matsuda J, Ohno R, Nakamura A, Kamei S, Ohno K, Kawamura T, Murata K.
    Radiat Med; 2005 Aug; 23(5):322-6. PubMed ID: 16342903
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N, Yoshizawa T, Nelson KD, Wilson CA.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [Abstract] [Full Text] [Related]

  • 10. Quantitative magnetic resonance imaging in assessment of the blood-retinal barrier.
    Plehwe WE, McRobbie DW, Lerski RA, Kohner EM.
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):663-70. PubMed ID: 3366561
    [Abstract] [Full Text] [Related]

  • 11. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI.
    Berkowitz BA, Tofts PS, Sen HA, Ando N, de Juan E.
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3500-6. PubMed ID: 1464496
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.
    Kim H, Csaky KG, Gilger BC, Dunn JP, Lee SS, Tremblay M, de Monasterio F, Tansey G, Yuan P, Bungay PM, Lutz RJ, Robinson MR.
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):655-62. PubMed ID: 15671296
    [Abstract] [Full Text] [Related]

  • 14. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
    Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Ogura Y.
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
    [Abstract] [Full Text] [Related]

  • 15. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):673-8. PubMed ID: 17553304
    [Abstract] [Full Text] [Related]

  • 16. Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging.
    Kim SH, Csaky KG, Wang NS, Lutz RJ.
    Pharm Res; 2008 Mar 13; 25(3):512-20. PubMed ID: 17674155
    [Abstract] [Full Text] [Related]

  • 17. Episcleral implants for topotecan delivery to the posterior segment of the eye.
    Carcaboso AM, Chiappetta DA, Opezzo JA, Höcht C, Fandiño AC, Croxatto JO, Rubio MC, Sosnik A, Abramson DH, Bramuglia GF, Chantada GL.
    Invest Ophthalmol Vis Sci; 2010 Apr 13; 51(4):2126-34. PubMed ID: 19834044
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S, Inoue Y, Watanabe M, Izawa K, Shimada M, Tojo A, Yoshikawa K, Ohtomo K.
    Magn Reson Imaging; 2009 Jan 13; 27(1):101-7. PubMed ID: 18599243
    [Abstract] [Full Text] [Related]

  • 19. Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging.
    Sonoda A, Nitta N, Ohta S, Seko A, Jo J, Morikawa S, Tabata Y, Takahashi M, Murata K.
    Eur J Radiol; 2009 Sep 13; 71(3):570-5. PubMed ID: 18502598
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging.
    Port RE, Schuster C, Port CR, Bachert P.
    Cancer Chemother Pharmacol; 2006 Nov 13; 58(5):607-17. PubMed ID: 16506037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.